Because gastrointestinal (GI) illnesses can cause physical, emotional, and social distress, patientreported outcomes (PROs) are used to guide clinical decision making, conduct research, and seek drug approval. It is important to develop a mechanism for identifying, categorizing, and evaluating the over 100 GI PROs that exist. Here we describe a new, National Institutes of Health (NIH)-supported, online PRO clearinghouse -the GI-PRO database.
INTRODUCTION
Patients typically seek healthcare because they experience symptoms. Healthcare providers must elicit, measure, and interpret patient symptoms as part of the clinical evaluation. PatientReported Outcomes (PROs) capture the patients ' illness experience in a structured format ( 1 ) and may help bridge the gap between patients and providers. Health-related quality-of-life (HRQOL) measures capture health directly reported by the patient (e.g., physical, emotional, or social symptoms) and can help to direct care and improve clinical outcomes. When clinicians systematically collect HRQOL data in the right place at the right time, it can eff ectively aid in detection and management of Development of an Online Library of Patient-Reported Outcome Measures in Gastroenterology: The GI-PRO Database
METHODS

Study overview
We performed a structured search to identify English-language PROs across all luminal diseases and other illnesses that directly aff ect the GI tract (e.g., systemic sclerosis). We developed a search strategy that targets studies describing the development and evaluation of English-language PROs that measure GI symptoms, including physical, emotional, cognitive, and social symptoms attributable to disorders aff ecting the GI tract. We then abstracted individual items from each PRO, and developed a comprehensive item library that is searchable using an online relational database. We developed " bins " within which to categorize physical symptoms, and used this to assess a framework for GI physical symptom reporting, similar to one developed previously for irritable bowel syndrome (IBS) ( 14 ) , and a process supported by the NIH PROMIS network ( 13 ) . Finally, we categorized each PRO, and assigned a score for the methodological quality of each instrument. In the sections that follow, we describe our search strategy, abstraction methods, quality scoring, and development of the GI-PRO database.
Literature search
We performed a systematic review of PubMed, the Cochrane database, and the Patient-Reported Outcomes and Quality of Life Instruments Database (PROQOLID) to identify English-language publications from 1946 through January 2012. We developed our search strategy using PROMIS criteria in concert with an expert librarian (R.O.), and mirrored the approach employed by the University of Pittsburgh PROMIS investigators ( 12 ) . We next developed a set of keywords related to GI disorders using a combination of Medical Subject Headings (MeSH) and text words ( 15 ) . Aft er developing the search terms, we applied both the Pittsburgh strategy ( 12 ) and a previously validated PRO fi lter developed by Terwee et al. ( 16 ) , and compared retrieval sets. We added limits to the search strategy to fi nd English-language articles discussing human subjects.
Before fi nalizing our search strategy, we conducted pilot tests to troubleshoot any shortcomings in the fi lter. In test runs, we discovered two complications with the initial search strategy: the Pittsburgh fi lter did not include several known test articles relevant to our target population, and the Terwee fi lter included a large number of citations whose topics were beyond the scope of the project. In order to fi ne-tune the fi lters for our purposes, we developed a test set of 42 known PROs indexed in PubMed that we determined must be included in the fi nal search. We employed this test set to update the search strategy that we iteratively modifi ed to optimize sensitivity. To combine, modify, and create our fi nal search strategy, we reviewed the search concepts in a group session with the librarian to identify salient text words and MeSH terms from both the Pittsburgh and Terwee fi lters. To guide triage decisions about retaining search terms, we focused on concept relevance and potential for error (e.g., multiple meanings of a term causing irrelevant retrieval). We identifi ed variants of terms, including British spellings and alternate plurals for phrase searches, and included these permutations as part of the revised fi lter. As we reviewed terms for inclusion or exclusion, we iteratively verifi ed the fi lter against the set of known articles to identify potential for error. Of the 42 known articles, we retrieved all but one using the fi nal search strategy. Th e missing article was not in English and was therefore ineligible, as we focused on English-language articles. Table 1 provides the fi nal search strategy.
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Study selection
Four authors (P.K., N.A., B.M.R.S., and D.K.) reviewed the citations generated from the search strategy. We divided the review into three stages: titles, abstracts, and manuscripts. Pairs of reviewers assessed each generated title for relevancy, and rejected titles that fulfi lled one of the following explicit exclusion criteria: (i) not written in English, (ii) did not concern a clinical question relevant to human subjects, (iii) did not pertain to a luminal disorder, or illness with GI manifestations; (iv) did not pertain to PROs or diseases severity / activity indices; (v) referred only to objective disease markers, including radiographic, histologic, biochemical, endoscopic, or stool markers; (vi) referred to a translation of existing instruments into other languages; and / or (vii) was a self-described editorial, review article, letter, case reports, or opinion piece.
We included PROs that exclusively included items measuring physical, emotional, or social symptoms as reported by the patient. Instruments that measure disease activity via biomarkers (i.e., lab studies, endoscopic fi ndings, clinical fi ndings, and so on) were excluded. For example, the Crohn ' s Disease Activity Index is a severity scale that includes biomarker data and physical examination fi ndings, and was therefore excluded. Th is does not mean the Crohn ' s Disease Activity Index is unimportant or that it includes some PRO information -but simply indicates that it is not exclusively patient-reported information.
We next sought to identify and resolve discordant assessments between reviewers. Th is occurred through discussion between the two raters and, if there was uncertainty, included oversight by a third-party arbiter who reviewed and discussed the discordant titles. We remained conservative by accepting a title if there was uncertainty about how best to deliberate.
Th e reviewers then assessed the relevancy of all abstracts corresponding with the remaining titles, and excluded abstracts for the following reasons: (i) fulfi lled one or more of the title exclusion criteria, and (ii) did not provide original data (or was solely a review article). For the last cycle, the reviewers evaluated the relevancy of all manuscripts corresponding with the remaining abstracts, and included manuscripts if they featured PRO items pertaining to GI symptoms and their dimensions. We then performed manual reviews of the reference lists from key review articles to identify additional studies missed by the computer-assisted searches. The four search groups were combined as follows: (1 AND 2 AND 3 NOT 4). The search focused exclusively on English-language publications.
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Interrater reliability was measured using the κ -statistic. Th e κ refers to interrater agreement between two independent raters evaluating titles and abstracts from the literature search, assigning either " accept " or " decline " to each title or abstract. We calculated a standard unweighted κ based on the resulting 2 × 2 table, using the standard formula = (observed agreement − expected agreement) / (1 − expected agreement) ( 17 ) .
Item " binning "
We shared the fi nal list of instruments with three GI experts with experience in PRO development (William Chey (University of Michigan), Douglas Drossman (University of North Carolina), and Jan Irvine (University of Toronto)). We asked the experts to comment on the comprehensiveness of the search and identify potentially missing instruments. We then developed a framework of " bins " and " subbins " to categorize GI symptoms contained within PRO measures. " Binning " is a structured process, described and endorsed by the NIH PROMIS network, to position individual PRO items within posited domains ( 13 ) . Using a top-down approach, we fi rst defi ned a set of predefi ned bins as recommended by the PROMIS domain protocol documentation ( 13 ) . We remained fl exible to add new bins for items that did not easily fi t into a predefi ned bin. We established key words for each bin, and assigned each PRO item a bin label. Th is resulted in a conceptual framework of bins for categorizing GI physical symptoms, along with a list of individual items within symptom bin. We then summarized this information and made it available in our online GI-PROS database, as described below.
Quality scoring of PROs
Following collection of existing PROs, development of bins, and categorization of PRO items within bins, we assigned a quality score to each PRO instrument. We employed a checklist of PRO methodological " best practices " based on previously developed quality scores, including the Evaluating the Measurement of Patient-Reported Outcomes (EMPRO) ( 18 ) and the COnsensusbased Standards for the selection of health status Measurement INstruments (COSMIN).
EMPRO has 39 items that assess 8 attributes: conceptual and measurement model, reliability, validity, responsiveness, interpretability, burden, alternate modes of administration, and cross-cultural and linguistic adaptations of measures ( 18 ) . COSMIN includes over 100 items that assess 12 PRO attributes: internal consistency, reliability, measurement error, content validity, structural validity, hypothesis testing, cross-cultural validity, criterion validity, responsiveness, interpretability, generalizability of results, and item response theory ( 19 -22 ) . Both checklists are limited by their very high response burden, and the COSMIN is further limited by a low interrater reliability ( 19 ) .
In light of these shortcomings, we modifi ed the instruments to develop a brief checklist of methodological best practices that is tenable for use in evaluating a large number of instruments. Th e resulting checklist consists of eight items used to evaluate key properties of PRO instruments: (i) item writing process, (ii) content validity, (iii) reliability of measures, (iv) reliability for multiple English-language subgroups, (v) construct validity, (vi) interpretability, (vii) response burden, and (viii) mode of administration. Six of the items have a polytomous rating scale and two have a dichotomous response scale ( Table 2 ). Detailed defi nitions of the checklist items are available on the website.
Development of online database
We developed a publicly available online PRO library, called the GI-PRO database, for users to identify and categorize all available English-language GI PROs identifi ed by our search strategy. We programmed the relational database with the following forward and backward search functions:
PRO-level search: users can enter the name of a known PRO to access information about the instrument, including the name of its developers, year of publication, supporting manuscript information, domain coverage, number of items, target conditions and populations, and quality checklist scores (forward search). Symptom-level search: users can enter a symptom of interest (e.g., pain, bloating, diarrhea, incontinence, and so on) to access a list of all questionnaires with items that pertain to the target symptom (backward search). Th is allows the user to view a list of every permutation of the symptom published to date, as identifi ed by our search.
A list of searchable key terms is available in Appendix 1 .
RESULTS
Search results
Th e search strategy identifi ed 15,697 titles, of which 183 met our fi nal inclusion criteria ( κ > 0.6 for title and abstract selection). Th ere were 121 PRO instruments, comprising 2,372 items, described in the included studies. Th e expert panel identifi ed 5 additional instruments that were not captured in our systematic review, for a total of 126 instruments. Th e majority of PROs had one publication and we found that there was a mean of 1.25 publications per PRO (s.d. = 0.72; range 1.00 -5.00; median 1.00). A higher number of publications per PRO were associated with higher quality as subsequent publications assessed quantitative aspects such as longitudinal assessments and minimally important diff erences. Th e PROs cover a range of conditions, including achalasia ( 23 ), celiac sprue ( 24, 25 ) , dyspepsia ( 26 -43 ) , eosinophilic esophagitis ( 44 ), fecal incontinence ( 45 -60 ), functional GI disorders ( 25,41,49,53,60 -86 ) , gastroesophageal refl ux disease ( 30,38 -40,43,87 -110 ) , GI malignancies ( 48,77,111 -115 ) , postgastrectomy ( 113, 116 ) , ileal conduit diversion ( 117 ), ileostomy ( 118 ) , infl ammatory bowel disease ( 119 -127 ), pregnancy-related GI symptoms ( 128 -130 ) , systemic sclerosis ( 131 -133 ) , and radiation enteritis ( 57 ), among others. In all, 15 PROs apply to the pediatric population ( 44,45,60,77,80,97,100,102,115,123,124,134 -137 ) , and 6 apply specifi cally to women ( 56,128 -130,138,139 ) .
Item binning
Th e conceptual framework in Figure 1 represents the major GI symptom bins identifi ed by our literature search. Th e framework The checklist evaluated patient-reported outcomes (PROs) using all published articles with information on psychometric properties of the instrument. There are eight checklist items and the possible score range is 0 -20. Availability of the instrument in languages other than English is not factored in because the primary focus is use of the instrument in English language. Other coding approaches (e.g., EMPRO and COSMIN (COnsensus-based Standards for the selection of health status Measurement Instruments)) give credit for availability of language translations. posits that GI symptoms are represented by eight content bins: (i) abdominal pain, (ii) bloat / gas, (iii) diarrhea, (iv) constipation, (v) bowel incontinence / soilage, (vi) heartburn / refl ux, (vii) swallowing, and (viii) nausea / vomiting. We discuss each bin further in the following paragraphs.
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Abdominal pain . Of the included PROs, 12 included symptoms of abdominal pain ( 41,44,49,61,63,66,114,131,134,140 -142 ) . Th e PROs reveal that abdominal pain is multifaceted; PRO items cover many dimensions of abdominal pain, including intensity, frequency, bothersomeness, location, and pain interference.
Gas / bloat . Of the included PROs, 15 included symptoms related to gas, fl atus, and bloating ( 30, 49, 56, 62, 63, 66, 71, 76, 82, 84, 88, 99, 114, 140, 143 ) . Th e PRO items can be divided into patient descriptions of the look vs. feel of bloating, as we have also discovered in previous qualitative work ( 14 ) . Many PRO items refer to " fl atulence " as a related but separate symptom that indicates passing gas (in contrast to perceived gas retention with subsequent visible bloating). In addition, many PRO items refer to " gurgling, " or " rumbling " of contents inside the belly. We currently group these latter symptoms within the gas / bloat / fl atulence domain. Bowel incontinence / soilage . Previous research, focused in IBS, revealed that incontinence is a separate bin from urgency ( 14 ) . Our search yielded 16 PROs with items pertaining to bowel incontinence ( 45 -60 ) . Th is bin includes a spectrum of symptoms ranging from leakage, underpant soilage, and outright incontinence. It is noteworthy that these PRO items were oft en distinct from urgency or diarrhea, again suggesting a stand-alone bin for incontinence / soilage. Nausea / vomiting . Our search revealed 11 PROs with items pertaining to nausea and vomiting ( 44,66,110,115,128 -130,136,137, 140,148,149 ) . Th ese items capture a range of increasingly severe foregut symptoms that begins with feeling sick to the stomach and ends with vomiting up stomach contents. Intermediate symptoms include low appetite, feeling sick to the stomach, dry heaving, and queasiness in the belly.
Gastroesophageal refl ux (GER)
. We identifi ed 29 PROs with items pertaining to GER ( 30,38 -40,43,87 -109 ) . Patients with GER experience a wide range of foregut symptoms. Our review of extant items, coupled with evaluation of focus group results, identifi ed four subdomains of GER symptoms, including: (i) liquid and food sensations (refl ux, regurgitation, choking, badtasting liquids), (ii) painful sensations (heartburn, chest pain,
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true in GI, where most illnesses announce themselves through patient-reported symptoms rather than abnormal biomarkers. We have developed an online clearinghouse of PROs that pertain to luminal digestive diseases -the GI-PRO database -that is now available to help clinicians, researchers, clinical trialists, and educators identify available GI PROs, evaluate their characteristics, and assess their level of methodological quality.
Th e database provides a novel way to identify GI PROs. Th e PRO repository may be useful for clinical studies and clinical practice. For example, researchers interested in fi nding an HRQOL measure for a study can readily access disease-targeted measures from the website. In addition, clinicians seeking PROs throat burn), (iii) belching gas / hiccups, and (iv) head and neck sensations.
Disrupted swallowing . We identifi ed 13 PROs with items pertaining to disrupted swallowing, including dysphagia and odynophagia symptoms ( 23,30,44,58,88,90,106,108,112 -114,143,144 ) . Patients with disrupted swallowing describe a range of symptoms ranging from transient food " sticking " to complete inability to swallow solids or liquids. Th ese symptoms typically progress along a clinical spectrum, as captured in the extant items in the literature.
Psychological symptoms, social symptoms, and health behaviors
In addition to physical symptoms, published GI PROs cover a range of psychosocial symptoms attributable to GI disorders. Table 3 provides a list of psychosocial domains within the PROs identifi ed by our search. Th e table highlights the breadth and depth of psychosocial illness experiences of GI patients. In addition, many PROs address health behaviors attributable to GI diseases. Th ese can be classifi ed into avoidance and restrictive behaviors (e.g., avoiding social events, travel, or culprit foods), proactive and preventative behaviors (e.g., wearing loose fi tting clothes, staying near bathrooms, exercising to avoid GI symptoms), and reactive behaviors (e.g., taking medicines, running to the bathroom, separating from others during symptoms, applying heating pads). Table 4 provides the results of quality scoring. Th e mean score was 8.88 (s.d. = 4.19) out of 20 (higher indicates better). Only 59 % of instruments provided information on how to interpret scores, and 51 % did not include any patient input in developing the PRO instrument. Only 46 % of GI PROs were based on cognitive debriefi ngs of the items. Th e results of the full checklist are presented in Table 4 . Table 5 lists the highest scoring instruments by disease category.
Quality scoring
Online PRO library
The online library is accessible at http://www.researchcore. org/gipro/ and on the homepage of www.ResearchCORE.org . Figure 2 provides a screenshot of the main search page of the GI-PRO database and demonstrates the results of search. Users can employ the database to conduct forward and backward searches of PRO instruments, domains, and individual items.
DISCUSSION
Healthcare providers measure and interpret the patient report in order to direct clinical decision making. Th e literature suggests that HRQOL measurement can aid in detection and management of conditions ( 2,3 ), improve patient satisfaction ( 4 ), and enhance the patient -provider relationship at the center of chronic disease care ( 4 -8 ) . For this reason, it is important to have a systematic accounting of the available PROs. Th is is especially 
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Second, based on a structured review of the available PROs, we developed a framework for categorizing GI physical symptoms ( Figure 1 ). According to this framework, almost every GI symptom can be " binned " into one of the eight categories . Th is parsimonious model indicates that the alimentary tract is surprisingly effi cient in its symptom expression; the symptom dictionary is relatively narrow. Whereas the variety of underlying GI disorders is expansive, their symptom expressions funnel into a narrow taxonomy of defi ned presentations.
Our research group used this framework to develop a GI item bank for the PROMIS consortium -an NIH Roadmap Initiative with the goal of building, evaluating, and disseminating a toolbox of publicly available PRO item banks across the human illness experience. Th e PROMIS item banks are diff erent from traditional paper-and-pencil questionnaires, because they can be electronically administered using computerized adaptive testing based on item parameters estimated using item response theory ( 150, 151 ) . Th is yields highly effi cient and short questionnaires that can be implemented in busy clinical systems while preserving reliability and validity. Each PROMIS item bank is based on an underlying framework derived from several sources, including literature searches. With this background, we used the framework in Figure 1 to serve as the backbone for our GI item bank for PROMIS ( www.nihpromis.org ). Based on this symptom framework, the PROMIS GI bank provides a multidimensional tool for measuring symptoms across the full breadth and depth of GI conditions. Th ird, we found that the existing GI PROs measure a wide range of psychosocial symptoms. Th is emphasizes that GI illnesses not only generate physical symptoms, but also impact emotional, cognitive, and social functioning. Table 3 reveals the full range of psychosocial subscales contained within the existing GI PROs. It is now possible, using the GI-PROs database, to effi ciently search or individual questions to evaluate a patient ' s symptoms or biopsychosocial illness context can obtain guidance from PROs listed in the registry. For example, clinicians may seek guidance for how best to measure the HRQOL impact of IBS, and upon reviewing the PRO off erings may enhance their approach to illness assessment in a patient with chronic IBS symptoms. Th is repository may also serve as a resource to learn more about the breadth and depth of symptoms for common GI illnesses, as the online library encompasses the full spectrum of common GI diseases. Our study has fi ve key fi ndings. First, using an NIH-endorsed strategy of systematic review, we identifi ed over 100 PROs (to date) that pertain to luminal GI illnesses. In light of this extensive collection of PROs, interested stakeholders may benefi t from our GI-PROs database to help them navigate the PRO terrain in GI. (see table 2 for the complete checklist for methodological quality scoring).
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to health behaviors that ultimately aff ect overall HRQOL . Th e existing GI PROs sample from across this spectrum. Finally, we found that the overall methodological quality of GI PROs is typically not high (with notable exceptions). For example, only 46 % of PROs relied on patients to develop the content of the questionnaire. Th is is problematic, because patients are the gold standard for content development, and are, in fact the " P " in PRO. As mandated by the FDA ( 152 ) and the NIH ( 13 ) protocols for PRO development, future GI PROs must rely on patients, fi rst and foremost, for item development. In addition, these terms to identify PROs that measure each concept. In addition, the GI-PROs database allows users to view the terminology employed by PROs to capture psychosocial symptoms in GI.
Fourth, we found that many PROs measure health behaviors related to GI illnesses. Th ese behaviors can be divided into avoidance and restrictive behaviors (e.g., avoiding social events), proactive and preventative behaviors (e.g., wearing loose fi tting clothes), and reactive behaviors (e.g., taking medicines). Th is points out the continuum of patient reporting: physical symptoms may have an aff ective consequence (e.g., bother) that leads Figure 2 . Screenshot of GI PRO online library. Users initially view a text box in which any term can be entered that is relevant for a search of gastrointestinal (GI) patient-reported outcome (PRO) instruments. Examples include names of known instruments (e.g., IBS-QOL, PAGI-QOL, IBDQ), names of diseases (e.g., gastroesophageal refl ux disease (GERD), dyspepsia, Crohn ' s, Celiac), symptoms (e.g., bloating, diarrhea, constipation, nausea, pain), or healthrelated quality-of-life domains (e.g., sleep, fatigue, impact, embarrassment, depression). The example below shows the result of searching for " GERD " . Users can select individual instruments to obtain detailed information about them (e.g., inset shows details of ReQuest instrument).
GI-PRO Database patients should carefully review the resulting items before accepting them as fi nal. Th e usual approach is to conduct cognitive debriefi ng interviews that allow patients to evaluate items and their response scales. Cognitive interviewing is a powerful tool for gaining a better understanding of the underlying or covert process involved in responding to survey items through the use of verbal probing techniques ( 153, 154 ) . Only 52 % of GI PROs in this review involved patients in cognitive debriefi ng of candidate items. Another shortcoming is that virtually none of the PRO studies provided data across important patient subgroups. For example, the performance of PROs across gender, age, or race remains largely unknown. Th e PROs are further limited by rarely providing data on how to interpret the scores generated by the instruments. Without knowing the minimally clinically important diff erence on a scale, it is diffi cult to establish the meaning of PRO improvements or decrements over time. Finally, only 29 % of studies provided data on the response burden of the PRO to patients. As PROs move into everyday care ( 152, 155 ) , it will be increasingly important to develop instruments that are effi cient and easily administered in busy clinical environments.
Our database has several strengths. First, it is in the public domain -funded by the NIH and available to all interested stakeholders, including clinicians, researchers, and patients themselves. We relied on a rigorous systematic review using an NIH-endorsed search strategy and supplemented our review by reaching out to experts in the fi eld. In addition to providing descriptive information about existing PROs, we provide quantitative information about the methodological quality of these instruments using a checklist. We hope that aft er reviewing the checklist, researchers will have a better idea of what characteristics are needed to develop a high-quality PRO. Although this exercise was not specifi cally intended to " grade " PROs, but rather document their fundamental characteristics, researchers will be able to see which published instruments have the elements on our checklist. Th is will help guide development of PROs from researchers as it will provide a list of instruments with sound methodology. Finally, we have programmed the database to be highly functional, providing users with a unique interface to efficiently search the existing GI PROs. In time, we intend to expand the GI-PROs database as new instruments are published -an ongoing process. In addition, we hope this model will serve as an impetus for other subspecialists to evaluate their own PRO literature and consolidate the fi ndings using a similar database structure.
Our database also has important limitations. In particular, quality scoring is an imprecise science; subjectivity can easily undermine a seemingly rigorous scoring system. Th is is well known to the developers of previous PRO quality assessment scores ( 19 ) , and is not lost on us. We anticipate that many of our quality scores are debatable and are dynamic (as publications continue to improve quality scoring), and we remain modest in our assessments to date. If PRO authors believe our assessments are incorrect, then we will remain open and fl exible to consider updates to our existing scores in an eff ort to improve this shared, publicly available resource (to express any concerns about the accuracy of the database, please go to http://www.researchcore.org/gipro ). Indeed, one benefi t of an online, dynamic database is the ability to update its information at any time. Furthermore, as more data are collected for a PRO, quality scores can be updated to keep pace with incremental information. Another limitation is that we limited our database to English-language PROs. Although most PROs are in English, there are undoubtedly many outstanding instruments in other languages. With more time and resources, the GI-PROS database could be expanded to include the non-English literature. Our original abstractions did not collect data on translations or translatability as well; future work will aim to include these important attributes of the included PROs. In addition, despite our extensive search, it remains likely that we have missed some PROs, and hence we acknowledge that this library is a work in progress and that some PRO instruments, especially those related to luminal GI disorders other than IBS, may have been missed. We welcome notifi cation of an oversight, and remain open to update the database to incorporate all eligible PROs. Finally, we developed a streamlined quality checklist based on previously developed quality scores such as EMPRO ( 18 ) and COSMIN checklists ( 19 -22 ) . However, these checklists have over 140 items that assess every possible attributes of PRO measures; as such, they are highly cumbersome and time consuming. To populate our database, we sought to simplify the process to avoid the high response burden and low interrater reliability of existing scoring methods. As a result, we did not capture all aspects of methodological quality, but instead focused on particular areas of importance.
In summary, we have developed a publicly available online library of PRO measures that itemizes physical, emotional, and social symptoms pertinent for patients with GI distress. Th e GI-PROS database is searchable at multiple levels, including PROs, domains, individual items, and methodo logical quality.
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APPENDIX 1
List of searchable terms
